Ensifentrine, a novel dual phosphodiesterase (PDE) 3 and 4 inhibitor, provides effective bronchodilation when administered by dry powder inhaler in COPD Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019
Inhaled long-acting β2 -agonist: aerosol particle size and bronchodilator response Source: Eur Respir J 2005; 26: Suppl. 49, 126s Year: 2005
Sub-microgram dose formulations for dose ranging studies with long acting bronchodilators and their fixed dose combination using metered dose inhalers (MDIs) Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013
No interaction of roflumilast, a new, orally active, selective PDE4 inhibitor, with inhaled salbutamol Source: Eur Respir J 2001; 18: Suppl. 33, 156s Year: 2001
In vitro fine particle dose of drug formulation used in asthma & COPD Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020
Effective and efficient nebulization of alpha1 -proteinase inhibitor (alpha1 -PI) for inhalation therapy using the AKITA2 ® APIXNEBÔ nebulizer system Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010
Similar delivery of ipratropium bromide is possible at approximately one-half dose via a breath-actuated nebulizer compared with a continuous nebulizer Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005
Roflumilast, a new, orally active, selective PDE4 inhibitor, does not interact with inhaled budesonide Source: Eur Respir J 2001; 18: Suppl. 33, 156s Year: 2001
Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation Source: Eur Respir J 2011; 38: 1328-1335 Year: 2011
Pharmacokinetics (PK) of a single dose AZD7594 administered intravenously (IV), orally, and inhaled via two dry powder inhalers (DPI) and a pressurized metered-dose inhaler (pMDI) Source: International Congress 2017 – Pulmonary drug and devices delivery Year: 2017
A novel submicron budesonide suspension demonstrates equivalent nebulization times compared to cyclodextrin-based solution formulations Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Comparison of valved-holding chamber (VHC)-facemask/mouthpiece with small volume nebulizer-facemask (SVN-F) for bronchodilator delivery Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009
Bronchodilator effect of formoterol delivered by two different dry powder inhalers (DPI) Source: Eur Respir J 2004; 24: Suppl. 48, 310s Year: 2004
In vitro analysis of two formulations of fluticasone/ salmeterol pMDI for delivered dose uniformity and aerodynamic particle size distributionSource: International Congress 2014 – Rationale behind respiratory drug development Year: 2014
The GOLDEN-1 study: Safety and bronchodilatory effects of nebulized glycopyrrolate (EP-101) using high efficiency nebulizer in patients with COPD Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
A submicron suspension of budesonide improves the mass of ICS delivered during early nebulization Source: Eur Respir J 2006; 28: Suppl. 50, 712s Year: 2006
Variability of budesonide (BUD) fine particle dose (FPD) delivered through two multiple dose dry powder inhalers (MDPI) Source: Eur Respir J 2004; 24: Suppl. 48, 582s Year: 2004
A breath-actuated jet nebulizer (BAN) has dosimetric capability for a suspension formulation based on differing volume fill of medication as well as run time Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II Year: 2010
A novel breath-actuated vortex spacer device increases respirable dose delivery of fluticasone/salmeterol in combination Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008
In vitro aerosol delivery by vibrating mesh nebulizer (VMN) and pressurized metered dose inhaler (pMDI) using spacers in comparison with T adapters in mechanical ventilation. Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020